| Alberta | British Columbia | Manitoba | New Brunswick | Newfoundland | Nova Scotia | Ontario | PEI | Quebec | Saskatchewan |
---|---|---|---|---|---|---|---|---|---|---|
Undiscounted lifetime cervical cancer cases | ||||||||||
Vaccine A | 223 | 71 | 23 | 8 | 6 | 11 | 269 | 2 | 208 | 11 |
Vaccine B | 237 | 78 | 25 | 10 | 7 | 13 | 288 | 2 | 240 | 13 |
Difference (A- B) | −14 | −8 | −2 | −2 | −1 | −2 | −19 | 0 | −32 | −2 |
Undiscounted short-term budget impact (CAD) | ||||||||||
Vaccine A | 8 862 430 | 3 431 536 | 1 071 737 | 1 039 079 | 673 843 | 1 244 617 | 11 758 847 | 173 180 | 14 284 003 | 1 426 186 |
Vaccine B | 8 862 430 | 3 431 536 | 1 071 737 | 1 039 079 | 673 843 | 1 244 617 | 11 758 847 | 173 180 | 14 284 003 | 1 426 186 |
Difference (A-B) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Discounted long-term budget impact (CAD) | ||||||||||
Vaccine A | 71 372 551 | 15 984 442 | 4 131 005 | 2 865 649 | 1 858 981 | 3 600 539 | 48 811 638 | 491 961 | 58 240 107 | 3 861 885 |
Vaccine B | 72 015 197 | 16 091 773 | 4 155 215 | 2 890 712 | 1 874 203 | 3 630 560 | 49 128 834 | 495 873 | 58 720 943 | 3 894 102 |
Difference (A-B) | −642 645 | −107 331 | −24 210 | −25 063 | −15 222 | −30 021 | −317 196 | −3 912 | −480 836 | −32 217 |